Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: A prospective, clinic-based study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Drain, Paul K ^a,b   Losina, Elena ^a,b,c   Coleman, Sharon M ^c   Giddy, Janet ^d   Ross, Douglas ^e   Katz, Jeffrey N ^b   Walensky, Rochelle P ^a,b   Freedberg, Kenneth A ^a,b   Bassett, Ingrid V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d MCCORD HOSPITAL   (South Africa)

^e St Mary's Hospital   (South Africa)

Author keywords

Diagnostic testing; HIV AIDS; Lipoarabinomannan (LAM); Screening; South Africa; Tuberculosis; Urine

Indexed keywords

LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; RAPID URINE LIPOARABINOMANNAN TEST; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS; TUBERCULOSIS RAPID TEST; URINALYSIS; COMPLICATION; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY; URINE;

ADULT; AMBULATORY CARE FACILITIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY; URINALYSIS;

EID: 84895559411     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-110     Document Type: Article

References (28)

1. World Health Organization Global tuberculosis control 2011 2011, Geneva: World Health Organization, World Health Organization.
2. World Health Organization Joint TB/HIV Interventions 2009, Geneva: World Health Organization, World Health Organization.
3. World Health Organization TB/HIV Working Group 2010, Geneva; World Health: Priority research questions for HIV/TB in HIV-prevalent and resource-limited settings, World Health Organization.
4. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009, 23(14):1875-1880. 10.1097/QAD.0b013e32832e05c8, 20108382.
5. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, Mazibuko M, Bearnot B, Allen J, Walensky RP, Freedberg KA. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010, 51(7):823-829. 10.1086/656282, 3204934, 20735240.
6. Hassim S, Shaw PA, Sangweni P, Malan L, Ntshani E, Mathibedi MJ, Stubbs N, Metcalf JA, Eckes R, Masur H, Komati S. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clin Infect Dis 2010, 50(7):1053-1059. 10.1086/651119, 2947351, 20196651.
7. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J, Aledort JE, Hillborne L, Rafael ME, Girosi F, Dye C. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 2006, 444(Suppl 1):49-57.
8. Saito S, Howard AA, Reid MJ, Elul B, Scardigli A, Verkuijl S, Nyaruhirira AU, Nash D. TB diagnostic capacity in sub-Saharan African health care settings. J Acquir Immune Defic Syndr 2012, 61(2):216-220. 10.1097/QAI.0b013e3182638ec7, 3890234, 22732465.
9. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampin resistance. New Engl J Med 2010, 363(11):1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
10. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377(9776):1495-1505. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
11. World Health Organization Global Plan to Stop TB 2011-2015 2010, Geneva: World Health Organization, World Health Organization.
12. Stop TB Partnership & World Health Organization An international roadmap for tuberculosis research: towards a world free of tuberculosis 2011, Geneva: World Health Organization, Stop TB Partnership & World Health Organization.
13. Brennan PJ. Structure, function, and biogenesis of the cell wall of mycobacterium tuberculosis. Tuberculosis (Edinb) 2003, 83(1-3):91-97. 10.1016/S1472-9792(02)00089-6, 12758196.
14. Reither K, Saathoff E, Jung J, Minja LT, Saad E, Huggett JF, Ntinginya EN, Maganga L, Maboko L, Hoelscher M. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis 2009, 9:141. 10.1186/1471-2334-9-141, 2741465, 19715562.
15. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting. J Acquir Immune Defic Syndr 2009, 52(2):145-151. 10.1097/QAI.0b013e3181b98430, 2815254, 19692904.
16. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010, 5(3):e9848. 10.1371/journal.pone.0009848, 2844421, 20352098.
17. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis 2012, 12:103. 10.1186/1471-2334-12-103, 3423001, 22536883.
18. Alere Inc Determine™ TB LAM test 2013, USA: Waltham, http://www.alere.com/au/en/product-details/determine-tb-lam.html. (accessed March 22, 2013), Alere Inc.
19. Meintjes G, Maartens G, Boulle A, Conradie F, Goemaere E, Hefer E, Johnson D, Mathe M, Moosa Y, Osih R, Rossouw T, van Cutsem G, Variava E, Venter WDF, Spencer D, on behalf of the Southern African HIV Clinicians Society Guidelines for antiretroviral therapy in adults. S Afr J HIV Med 2012, 13(3):114-133. on behalf of the Southern African HIV Clinicians Society.
20. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Standards for Reporting of Diagnostic Accuracy Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003, 138(1):40-44. 10.7326/0003-4819-138-1-200301070-00010, 12513043, Standards for Reporting of Diagnostic Accuracy.
21. Liu TT, Wilson D, Dawood H, Cameron DW, Alvarez GG. Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Clin Dev Immunol 2012, 2012:937013. 3313559, 22474486.
22. Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, Boehme CC, Nicol MP. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis 2013, 13:407. 10.1186/1471-2334-13-407, 3846798, 24004840.
23. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12(3):201-209. 10.1016/S1473-3099(11)70251-1, 3315025, 22015305.
24. Dorman S, Manabe Y, Nicol M, Nakiyingi L, Moodley M, Zemanay W, Holshouser M, Perkins M, Alland D, Ellner J. Accuracy of Determine TB-Lipoarabinomannan lateral flow test for diagnosis of TB and HIV+ adults 2012, Seattle: 19th Conference on Retroviruses and Opportunistic Infection, Abstract #149aLB.
25. Peter JG, Theron G, van Zyl SR, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K. Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalized patients. Eur Respir J 2012, 40:1211-1220. 10.1183/09031936.00201711, 22362849.
26. Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, Dorman SE. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Micro 2010, 48:2972-2974.
27. Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis 2013, 17(4):552-558. 10.5588/ijtld.12.0627, 3918209, 23485389.
28. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. AIDS 2012, 26(13):1635-1643. 10.1097/QAD.0b013e3283553685, 22555166.